These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3569691)

  • 21. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free and lipid inositol, sorbitol and sugars in sciatic nerve obtained post-mortem from diabetic patients and control subjects.
    Mayhew JA; Gillon KR; Hawthorne JN
    Diabetologia; 1983 Jan; 24(1):13-5. PubMed ID: 6825977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sorbitol, inositol and nerve conduction in diabetes.
    Gillon KR; Hawthorne JN
    Life Sci; 1983 Apr; 32(17):1943-7. PubMed ID: 6835015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA; Mackway AM
    Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
    Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Yarasheski KE; Smith SR; Williamson JR; Peterson RG; Oates PJ
    Exp Neurol; 2005 Apr; 192(2):407-19. PubMed ID: 15755558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
    Berti-Mattera L; Day N; Peterson RG; Eichberg J
    Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental Diabetic Neuropathy.
    Freeman OJ; Unwin RD; Dowsey AW; Begley P; Ali S; Hollywood KA; Rustogi N; Petersen RS; Dunn WB; Cooper GJ; Gardiner NJ
    Diabetes; 2016 Jan; 65(1):228-38. PubMed ID: 26470786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes.
    Gabbay KH; Merola LO; Field RA
    Science; 1966 Jan; 151(3707):209-10. PubMed ID: 5907911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes.
    Palmano KP; Whiting PH; Hawthorne JN
    Biochem J; 1977 Oct; 167(1):229-35. PubMed ID: 588254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposite effects of diabetes and galactosaemia on adenosine triphosphatase activity in rat nervous tissue.
    Lambourne JE; Tomlinson DR; Brown AM; Willars GB
    Diabetologia; 1987 May; 30(5):360-2. PubMed ID: 2956144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.
    Tomlinson DR; Robinson JP; Compton AM; Keen P
    Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
    N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Dines K; Love A
    Diabetologia; 1992 Oct; 35(10):946-50. PubMed ID: 1451951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes and the myo-inositol paradox.
    Loy A; Lurie KG; Ghosh A; Wilson JM; MacGregor LC; Matschinsky FM
    Diabetes; 1990 Oct; 39(10):1305-12. PubMed ID: 2210080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
    Poulsom R; Mirrlees DJ; Earl DC; Heath H
    Exp Eye Res; 1983 May; 36(5):751-60. PubMed ID: 6406254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of nerve sugar levels for the peripheral nerve impairment of spontaneously diabetic GK (Goto-Kakizaki) rats.
    Suzuki K; Yen-Chung H; Toyota T; Goto Y; Hirata Y; Okada K
    Diabetes Res; 1990 May; 14(1):21-5. PubMed ID: 2134662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
    Mayer JH; Tomlinson DR; McLean WG
    J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
    Greene DA; Chakrabarti S; Lattimer SA; Sima AA
    J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.